These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 105416)

  • 21. Treatment of the severely burned child with skin transplantation modified by immunosuppressive therapy.
    Diethelm AG; Dimick AR; Shaw JF; Baker HJ; Phillips SJ
    Ann Surg; 1974 Dec; 180(6):814-8. PubMed ID: 4611358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human monocyte spreading. An in vitro test for immunosuppressive potency of antihum lymphocyte globulin.
    Silobrcić V; Mazuran R; Dekaris D; Balner H
    Transplantation; 1976 Jan; 21(1):51-6. PubMed ID: 813340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antilymphocyte serum produced by immunization with purified mouse thymocyte plasma membrane.
    Edwards AJ
    J Immunol Methods; 1979; 27(3):225-39. PubMed ID: 381524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific in vitro binding of radiolabeled antibodies to cell surface antigens: interaction of antihuman thymocyte globulin with human target cells.
    Garcia-Rinaldi R; Rossen RD; Hersh EM; Kormeier L; Butler WT
    J Immunol Methods; 1976; 9(3-4):235-49. PubMed ID: 814167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of anti-dog lymphocytic globulin raised with two cell types and immunization schedules.
    Collste LG; Groth CG; Kashiwagi N; Schantz B; Svehag SE
    Acta Chir Scand; 1972; 138(8):775-80. PubMed ID: 4565722
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoclonal antibody (WT 1) directed against a T cell surface glycoprotein: characteristics and immunosuppressive activity.
    Tax WJ; Tidman N; Janossy G; Trejdosiewicz L; Willems R; Leeuwenberg J; De Witte TJ; Capel PJ; Koene RA
    Clin Exp Immunol; 1984 Feb; 55(2):427-36. PubMed ID: 6199141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing effectiveness of antilymphocytic globulin by prevention of antibody formation to horse IgG.
    Butler WT; Rossen RD
    Transplant Proc; 1971 Mar; 3(1):733-6. PubMed ID: 4999467
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results.
    Simmons RL; Moberg AW; Gewurz H; Soll R; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):745-8. PubMed ID: 4999469
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunofluorescent assay of anti-human thymocyte globulin as a means of correlating "in vitro" and "in vivo" activity.
    Ablin RJ; Morrell RM
    Dev Biol Stand; 1974; 27():223-8. PubMed ID: 4618534
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
    Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS
    Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The production of immunosuppressive antisera.
    Barnes AD; Hawker RJ; Cowdall EI; Dickerson C; Dukes H; Griffin J; Crozier B; Fejfar J; Robinson BH; Blainey JD
    Proc Eur Dial Transplant Assoc; 1972; 9():364-70. PubMed ID: 4204156
    [No Abstract]   [Full Text] [Related]  

  • 32. Jurkat cell-reactive anti-thymocyte globulin assessed ex vivo by flow cytometry persists three weeks in circulation.
    Eiermann TH; Freitag S; Cortes-Dericks L; Sahm H; Zander AR
    J Hematother Stem Cell Res; 2001 Jun; 10(3):385-90. PubMed ID: 11454313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
    Fuson EW; Shaw MW; Hubbard RA; Lamon EW
    Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of human cultured lymphoblasts as a source of antigen for production of immunosuppressive antilymphocyte serum.
    Sell K; Woody J; Smith J; Darrow C; Kayhoe D
    Transplant Proc; 1973 Mar; 5(1):541-7. PubMed ID: 4633091
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Thomas FT
    Surg Forum; 1979; 30():282-3. PubMed ID: 120017
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressive ALS. II. Antibody to Ia antigens in heterologous anti-lymphocyte serum.
    Zimmerman B; Tsui F; Delovitch T
    Immunology; 1979 May; 37(1):179-86. PubMed ID: 381173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabbit anti rat lymphocyte serum: immunosuppression mediated by a pure IgM fraction.
    Jakobsen A; Flatmark A; Harboe M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Oct; 81(5):635-40. PubMed ID: 4209178
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved compatibility of ALG therapy by application of aggregate free globulin.
    Ring J; Seifert J; Seiler F; Brendel W
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):227-34. PubMed ID: 797668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
    Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
    J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative effectiveness of rabbit anti-mouse thymocyte sera in potentiating the survival of mouse skin or tumour allografts made across the H-2 barrier.
    Lai T; Symes MO
    Immunology; 1976 Jul; 31(1):21-6. PubMed ID: 800400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.